Research Champion
Rafael Freire
Associate Professor
Email: rafael.freire@queensu.ca
This research stream focuses on neurobiology, biomarkers, neurostimulation, and psychopharmacology in anxiety disorders and obsessive-compulsive disorders.
Key researchers in this stream
Elisa Brietzke
Professor, Department of Psychiatry, Queen’s University
elisa.brietzke@queensu.ca
Claudio Soares
Professor, Department of Psychiatry, Queen’s University
c.soares@queensu.ca
Current research projects
Trigeminal nerve stimulation in treatment-resistant generalized anxiety disorder: a feasibility study
PI: Rafael Freire
Co-investigators: Elisa Brietzke and Claudio Soares
A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder
PI: Rafael Freire
Co-investigators: Elisa Brietzke and Claudio Soares
Adjunctive Treatment with L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study
PI: Rafael Freire
Co-investigators: Elisa Brietzke and Claudio Soares
Publication list (last 5 years):
1. Al-Mahrouqi T, Al Alawi M, Freire RC. (2023) Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review. Clin Pract Epidemiol Ment Health.; 19:e174501792307240. doi: 10.2174/17450179-v19-230823-2023-4.
2. Freire RCR, Nardi AE. (2023) Is it possible to prevent relapse in panic disorder? Expert Rev Neurother.; 23(8):677-679. doi: 10.1080/14737175.2023.2229955. Epub 2023 Jun 26.
3. Brietzke E, Gomes FA, Gerchman F, Freire RCR. (2023) Should systematic reviews and meta-analysis include data from preprints? Trends Psychiatry Psychother.;45:1-2. doi: 10.47626/2237-6089-2021-0324. Epub 2021 Sep 8.
4. Faria CGF, de Matos UMA, Llado-Medina L, Pereira-Sanchez V, Freire R, Nardi AE. (2022) Understanding and addressing COVID-19 vaccine hesitancy in low and middle income countries and in people with severe mental illness: Overview and recommendations for Latin America and the Caribbean. Front Psychiatry.;13:910410. doi: 10.3389/fpsyt.2022.910410.
5. Garakani A, Freire RC, Buono FD, Thom RP, Larkin K, Funaro MC, Salehi M, Perez-Rodriguez MM. (2022) An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol. PLoS One, Vol. 17(6):e0269772
6. Ferreira-Garcia R, Costa MA, Gonçalves FG, de Nonohay RG, Nardi AE, Freire RCDR, Manfro GG. (2021) Heart rate variability: A biomarker of selective response to mindfulness-based treatment versus fluoxetine in generalized anxiety disorder. J Affect Disord.;295:1087-1092. doi: 10.1016/j.jad.2021.08.121. Epub 2021 Sep 2.
7. Kyriakoulis P, Kyrios M, Nardi AE, Freire RC, Schier M. (2021) The Implications of the Diving Response in Reducing Panic Symptoms. Front Psychiatry.;12:784884. doi: 10.3389/fpsyt.2021.784884.
8. Garakani, A.; Freire, R. C.; Murrough, J. W. (2021). Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls. Front Psychiatry, 12: 662963.
9. Freire, R. C. and V. A. Santos (2021). Features shared between fear of missing out on rewarding experiences (FOMO) and internet gaming disorder. Braz J Psychiatry, 43 (2): 129-130.
10. Zugliani, M.M., Fidry, M., Steffen, R., Lan, C., Brietzke, E., Milev, R., Nardi, A.E. and Freire, R.C. (2021). Clinical effectiveness of non-TMS neurostimulation in depression: Clinical trials from 2010 to 2020. Progress in Neuro-Psychopharmacology and Biological Psychiatry:110:110287. doi: 10.1016/j.pnpbp.2021.110287. Epub 2021 Feb 19.
11. Javelot, H., Weiner, L., Hingray, C., Freire, R. C., Nardi, A. E. (2020). COVID-19 and its psychological consequences: Beware of the respiratory subtype of panic disorder. Respir Physiol Neurobiol 282: 103530.
12. Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., Iosifescu, D. V. (2020). Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Front Psychiatry 11: 595584.
13. Faria, C. G. F., Fidry, M., do Cabo, M. C., Quagliato, L. A., Nardi, A. E., Zaman, R., Freire, R. (2020). A Brazilian Case of Treatment-Resistant Generalized Anxiety Disorder Successfully Treated with Monoamine Oxidase Inhibitor (MAOI). Psychiatr Danub 32(Suppl 1): 139-141.
14. Brietzke E, Magee T, Freire RCR, Gomes FA, Milev R. Three insights on psychoneuroimmunology of mood disorders to be taken from the covid-19 pandemic. Brain Behav Immun Health. 2020:100076.
15. Okuro RT, Freire RC, Zin WA, Quagliato LA, Nardi AE. Panic disorder respiratory subtype: psychopathology and challenge tests - an update. Braz J Psychiatry. 2020.
16. Freire RC, Ferreira-Garcia R, Cabo MC, Martins RM, Nardi AE. Panic attack provocation in panic disorder patients with a computer simulation. J Affect Disord. 2020;264:498-505.
17. Carta MG, Moro MF, Piras M, Ledda V, Prina E, Stocchino S, Orrù G, Romano F, Brasesco MV, Freire RC, Nardi AE, Tondo L (2020). Megacities, migration and an evolutionary approach to bipolar disorder: a study of Sardinian immigrants in Latin America. Braz J Psychiatry 42(1): 63-67.
18. Ferreira-Garcia, R., Faria, C. G. F., Nardi, A. E., Freire, R. C. D. (2019). Negative Affect Mediates Impulsivity in Generalized Anxiety Disorder. Psychopathology 52(6): 327-333.
19. Nardi AE, Freire RC, Kahn JP. The Master of Psychopharmacology: an inspiration for future generations - Donald F. Klein (1928-2019). Braz J Psychiat. 2019;41(6):465-6.
20. Fidry M, Zugliani MM, do Valle CR, Martins RM, do Cabo MC, Nardi AE, et al. Quality of life in panic disorder: the influence of clinical features and personality traits. Trends Psychiatr Psychother. 2019;41(4):387-93.
21. Santos VA, Hoirisch-Clapauch S, Nardi AE, Freire RC. Panic Disorder and Chronic Caffeine Use: A Case-control Study. Clin Pract Epidemiol Ment Health. 2019;15:120-5.
22. Balon R, Silberman EK, Starcevic V, Cosci F, Freire RC, Nardi AE, Rickels K, Shader R. Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency. J Psychopharmacol. 2019 Nov;33(11):1467-1470. doi: 10.1177/0269881119878171.
23. Quagliato LA, Cosci F, Shader RI, Silberman EK, Starcevic V, Balon R, Dubovsky SL, Salzman C, Krystal JH, Weintraub SJ, Freire RC, Nardi AE; International Task Force on Benzodiazepines. Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment. J Psychopharmacol. 2019 Nov;33(11):1340-1351. doi: 10.1177/0269881119859372.
24. Quagliato LA, Freire RC, Nardi AE. Elevated peripheral kynurenine/tryptophan ratio predicts poor short-term auditory memory in panic disorder patients. J Psychiatr Res 113:159-164, 2019. doi: 10.1016/j.jpsychires.2019.03.027.
25. Zugliani MM, Cabo MC, Nardi AE, Perna G, Freire RC. Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018. Psychiatry Investig 16(1):50-58, 2019. doi: 10.30773/pi.2018.12.21.1.
Research grants (internal and external)
Name of awarding organisation: Faculty of Health Sciences, Queen’s University
Amount in $CAN: 30,000
Duration of funding: 2 years
Name of awarding organisation: Biohaven Pharmaceuticals Inc.
Amount in $CAN: up to 243,000 (deliverable-based invoicing)
Duration of funding: open-ended
Name of awarding organisation: Department of Psychiatry, Queen’s University
Amount in $CAN: 10,000
Duration of funding: 1 year
Current students
-
Undergraduate: Hiroki Yasui – Queen’s University
-
MSc: Mariana Cabo – Federal University of Rio de Janeiro (co-supervision)
-
PhD: Morená Zugliani – Federal University of Rio de Janeiro (co-supervision)
Other information
Link to Queen's University Anxiety Research Lab (QAnxiety) - https://qanxiety.ca/
ResearchGate profile: https://www.researchgate.net/profile/Rafael_Freire
Web of Science profile: https://www.webofscience.com/wos/author/record/872338
Scopus: https://www.scopus.com/authid/detail.uri?authorId=34067584800
ORCID: https://orcid.org/0000-0003-3875-4601
Google Scholar: Rafael C R Freire - Google Scholar